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From 1968-1985 a series of thirty-seven patients with primary hepatocellular carcinoma was collected
from the tumor registry of the Fairfax County Hospital, in the metropolitan Washington, D.C. area.
These patients were found to have a mean age at diagnosis of sixty-two (males) to sixty-six (females).
Thirty per cent of patients were previously cirrhotic and nineteen per cent had a history of viral
hepatitis. There were no patients with documented birth control pill or steroid use. The most common
presenting symptoms were anorexia and right upper quadrant pain. Liver-spleen scan was the most
commonly used diagnostic study, but by the 1980’s CT scanning was usually diagnostic. Both alkaline
phosphatase and serum glutamyloxalotransferase were reliably elevated in twenty-six of twenty-eight
and twenty-one of twenty-four patients respectively. Forty-eight per cent of patients with tumor
histology reprted had multicentric tumors, thirty-eight per cent had nodular tumors, and fourteen per
cent had diffuse disease.
Survival was as dismal in this as in other studies with a mean of seventy-nine days. No significant
difference was noted between cirrhotic and non-cirrhotic patients. Chemotherapy and radiation therapy
did not significantly impact upon survival.
Finally, a cohort analysis was done and a possibly significant peak in incidence of primary
hepatocellular carcinoma was seen in men born from about 1911 through 1920. The authors noted that
these males were in the group of draft eligible persons for World War II and questioned a link between
veteran status and later development of HCC.
KEY WORDS: Carcinoma, liver, incidence, carcino-embryonic antigen, alpha-fetoprotein, veteran,
hepatitis, cirrhosis
SHORT SUMMARY
Primary hepatocellular carcinoma was examined in a hospital based epidemiologic
study. Demographic statistics were found to correlate with North American
averages. Two survivors were identified, both of whom underwent resection. A
cohort analysis was done which showed a peak in incidence of primary liver cancer
in males born between 1910-1920. A possible link with World War II veteran status
was postulated.
INTRODUCTION
Primary hepatocellular carcinoma is the most common malignancy worldwide with
a very high incidence in Africa and the Far East. 1’8 Various environmental, toxic,
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and infectious agents have been statistically and experimentally shown to be
relevant in the genesis of the disease. Chief among these are hepatitis B virus5’6’8’16
and alcoholic cirrhosis. 1’8’1’12’16’7 Because of the low incidence of this disease,
however, and because of its uniformly rapid fatality, few North American series
have been published. This report is a study of a series of patients collected at the
Fairfax County Hospital in the Washington, D.C., metropolitan area.
MATERIALS AND METHODS
Records of the tumor registry of the Fairfax County Hospital, a five hundred bed
private hospital in suburban Washington, D.C., were searched for both clinical and
autopsy diagnoses of primary hepatocellular carcinoma. Such records have been
kept at the hospital since 1968, thus a time frame of 1968-1985 was used for this
study. Following patient identification, hospital records were abstracted for demo-
graphic, pathologic, etiologic and diagnostic information. This data was then
collated to produce this report.
RESULTS
A total of 38 patients with a diagnosis of primary hepatocellular carcinoma were
identified. After examination of pathology reports, hospital records, and office
charts, one patient was eliminated from the study with a diagnosis of metastatic
colon cancer leaving a total of thirty-seven patients for analysis.
Of the thirty-seven patients in the study there were twenty-three males and
fourteen females (M:F ratio 1.6:1). Thirty-four patients were Caucasian, one black
and two Oriental. The two Oriental patients were both immigrants from Korea in
adulthood; one Caucasian was originally from the Dominican Republic. The
remaining thirty-four patients were native. The mean age of onset was in the sixth
decade in males (mean 62), and slightly older for females (mean 66). A limited
cohort analysis was done comparing native patients with the diagnosis of liver
cancer by sex and by birth year. A peak in incidence in males born 1911-1925 was
shown (Figure 1). Tumor pattern was reported in twenty-nine of thirty-seven
patients. Fourteen (48%) had multicentric tumors, eleven (38%) had nodular
tumors, and four (14%) had diffuse tumor.
The series was examined for co-morbid disease. (Table 1) Eleven patients were
reported as cirrhotic (30%). Ot these, five had Laennec’s cirrhosis, two had post-
hepatitic cirrhosis, and four patients had cirrhosis without pathologic type
reported. Seven patients were described as alcoholic (19%). Of these seven
patients, four had both documented alcoholism and cirrhosis. Seven patients had a
history of hepatitis of which six had hepatitis B, and two had known chronic active
hepatitis. No patients had documented birth control pill, or steroid use, and there
were no patients with hemochromatosis. One of the Korean patients had viral
cirrhosis, the other had alcoholic liver disease. The patient from the Dominican
Republic had alpha-l-antitrypsin deficiency. Two patients (5%) had a history of
cholelithiasis, and eight patients had other malignancies of widely varying and non-
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Figure Cohort analysis (birth year group vs. number in group).
Table 1 Other Medical Problems.
Cirrhosis 11 (30%)
Laennec’s 5
Post Hepatitic 2
Unknown Pathology 4
Alcoholism 7 (10%)
alcoholism with cirrhosis
documented 4
Viral Hepatitis 7 (19%)
Chronic Active Hepatitis
Other Malignancies 8 (23%)
Cholelithiasis 2 (5%)
Hemochromatosis 0 (0%)
BCP/steroid use documented 0 (0%)
Evaluation of presenting symptoms (Table 2) from these patients showed that
the most common symptoms, were anorexia and abdominal pain, usually originat-
ing in the right upper quadrant. Nearly one-quarter of the patients had an
abdominal mass at presentation. Two patients entered with a rapid decompensa-
tion of previously stable cirrhosis, a symptom suggested by many authors to be a14 J. D. SEDLACK AND R. J. NAUTA
hallmark of liver cancer in the cirrhotic. One patient, admitted with advanced
disease complained principally of rib pain from tumor erosion.
Many diagnostic studies are open to the clinician in the diagnosis of hepatocellu-
lar carcinoma (Table 3). In this study the most frequently utilized was nuclear liver
scanning reflecting the available technology of the late 1960’s and early 1970’s. By
the late 1970’s CT scanning was very frequently used and there was a decline in the
frequency of liver scanning. Three patients in our series were diagnosed only at
autopsy, a rate comparable to other American studies. Peritoneioscopy with liver
biopsy under direct visualization was done in only two patients, but with pathologic
diagnoses made in both.
There was a low rate of reporting of both Carcino-Embryonic Antigen (CEA)
and Alpha-fetoprotein (AFP) levels in our series (Table 3). One half of the AFP
levels reported were said to be normal. CEA levels were somewhat more reliably
elevated. SGOT and Alkaline Phosphatase levels were also found to be signifi-
cantly elevated in the majority of patients.
Table 2 Presenting Symptoms.
Anorexia 25 (68%)
Abdominal Pain 21 (57%)
Palpable Mass 9 (24%)
Ascites 7 (19%)
Hemorrhage 3 (8%)
Jaundice 3 (8%)
Decompensating Cirrhosis 2 (5%)
Rib Pain (3%)
Table 3 Diagnostic Studies.
liver scan 15 (41%)
percutaneous biopsy 14 (38%)
laparotomy 12 (32%)
peritoneoscopy 2 (5%)
ultrasound (3%)
diagnosis at autopsy 3 (8%)
alpha-fetoprotein 7 negative (or less than 5)
reported in 14 patients median value 100
Serum Glutamyloxalo- normal 10-41
transferase (SGOT) range 18-526
reported in 24 patients average 125
elevated in 21 patients
Alkaline Phosphatase normal 30-110
reported in 28 patients range 85-1585
elevated in 26 patients average 465
Carcinoembryonic antigen negative in
reported in 13 patients range 0-23.5
average 6.1PRIMARY HEPATOCELLULAR CARCINOMA 15
Approximately one-half of patients in the series underwent some form of
treatment. Three patients underwent liver resection, with one documented cure in
a young female patient undergoing liver resection in the early 1970’s. Another
patient, an elderly woman, underwent pre-operative chemotherapy and, several
years later resection of liver tumor mass surrounded by tumor free necrotic
margins. The third operative patient died perioperatively. Chemotherapy and
radiation therapy were used in a number of patients, usually as a final effort and
with no prolongation of life.
An analysis of survival was done (Table 4). The two cures were excluded from
survival data as were the three patients diagnosed at autopsy. The remaining
patients were also further divided into cirrhotic and non-cirrhotic groups because of
a slightly shorter reported survival in cirrhotic patients than in non-cirrhotic
patients. For the entire group, the survival range was one, to three-hundred and
fifteen days with an average of seventy-nine days. Non-cirrhotic patients tended to
live somewhat longer than the mean at ninety-three days and cirrhotic patients
somewhat less at forty-two days, though this was not statistically signficant by X
analysis of variance.
DISCUSSION
Patients with primary hepatocellular carcinoma in North America present a
difficult epidemiologic problem given their small incidence and quick demise. This
investigation of liver cancer in a suburban/metropolitan hospital in Virginia,
nonetheless yielded data for comparison with other North American studies and
provided a useful contrast with international data (Table 5). A cohort analysis was
done, which we have not seen elsewhere. Our study, though constrained by the age
skew of the hospitalized population from 1968-1985, showed a seemingly signifi-
cant peak in occurence of primary hepatocellular carcinoma in the group of native
males born from 1911 through 1925. Over one-half of our patients came from this
Table 4 Survival (excluding 2 "cures" and 3
diagnosed at autopsy 32 patients).
Overall
Range 1-315 Days
Average 78.8 Days
Standard Deviation 74.12 Days
Non-Cirrhotic Patients
(N 23)
Range 1-315 Days
Average 93.17 Days
Standard Deviation 80.8 Days
Cirrhotic Patients
(N=9)
Range 1-89 Days
Average 42 Days
Standard Deviation 35 Days16 J.D. SEDLACK AND R. J. NAUTA
Table 5 Institutional Experiences with Hepatocellular Carcinoma.
# Patients
Avg.Age
W o B Viral Hep.
Study M/F Cirrhosis Etoh CAH Other Malig. AFP
Luna 35 27 (77%) 16 (46%) 5
Seattle N.A. 4
28/5/2
31/4
Naga- 100 78 (78%) 39 (39%)
Sue N.A.
Japan
L.C.S.G. 1047 395 (44.8) 158 (15%)
Japan 55.9
0/1047/0
858/189
Lai 211 12 (6%) 23 (11%)
Hong "60’S"
Kong 0/211/0
177/34
Inouye 205 111 N.A.
Hi, USA 61
58/136/0
161/44
Chlebo- 121 (63%) (31-55%)
Wski 52
L.A., USA 722/26/30
90/31
Sedlack 37 11 (30%) 7 (19%)
D.C., USA 64
34/2/1
23/14
8 (23%) N.A.
43 (43%) N.A. + 54/83
24
457 (55%) N.A. N.A.
269
N.A. N.A. N.A.
19/20
N.A. + 9/30
10/10
(52%) N.A. N.A.
7 (19%) 8 (22%) + 7/14
2
group, a subset of males whose life was likely to have included service in World
War II. Seeff, et al.
19 have reported on the development of viral hepatitis in
American veterans of that war who received the Yellow Fever vaccination. As
"yellow jaundice" was endemic in troops stationed in Asia during that time, further
studies are indicated to determine if the veterans of the Pacific War are at an
increased risk of late development of hepatocellular carcinoma.
This study again pointed out the importance of liver disease, principally alcoholic
cirrhosis and viral hepatitis, in the genesis of primary liver carcinoma. Our
percentage of cirrhosis is lower than in other North American studies. There are
equal numbers of patients with alcoholic and with viral liver disease in our group,
comparable to other North American studies. 1’6
Only two patients were seropositive for hepatitis B surface antigen as compared
with higher rates in both Seattle and Los Angeles. Given the high rate of finding
hepatitis B virus genome incorporated into hepatocellular carcinoma and other
"normal" liver tissue in patients with the cancer, TM this raises the obvious question
of whether many tumor promoters exist for primary liver cancer.
No relationship was found between blood group and risk for primary liver
carcinoma, distinguishing liver carcinoma from many of the gastrointestinal tumors
with their predilection for a certain blood group, particularly group A.PRIMARY HEPATOCELLULAR CARCINOMA 17
Several studies have shown a significant number of patients with hepatocellular
carcinoma to have a history of other malignancies. This was demonstrated again in
this study, but the malignancies were all differing types and none contributed to the
patients’s eventual demise. We feel that given the high frequency of all types of
malignancy in the United States, the age of the population at risk for hepatocellular
cancer, and the scattershot distribution of other malignancies seen here, no
satisfactory link may be discerned.
The use of Alpha-fetoprotein measurements as a diagnostic tool cannot be
assessed from this study. Only fourteen out of thirty-five patients had the test,
reflecting the time frame of the study. The rate of positive testers of fifty per cent
compares unfavorably to other published reports from both the Orient and the
United States of seventy to one-hundred per cent positive
18 though it is known to be
most useful in screening the population with a viral carcinogen. Survival data in
those patients show an overall mean survival of under three months, with no
statistically demonstrable survival difference between cirrhotic and non-cirrhotic
patients, in contrast with several studies which show a slight decrease in survival of
cirrhotic patients.
Many issues are relevant to the study of hepatocellular carcinoma. Our study
showed an increased risk of carcinoma in males born between 1911 and 1925 for
unknown but possibly statistical reasons, and the standard North American equal
ratio of alcoholic to viral liver disease as predisposing conditions. More study of the
risks of hepatocellular carcinoma in North American males is needed to determine
their risk factors beyond ethanol and hepatitis especially with regard to veteran
status and travel history.
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INVITED COMMENTARY
It is very interesting that this paper concerns the epidemiologic and clinicopatholo-
gical studies of hepatocellular carcinoma in one of the areas with small incidence of
this disease.
In Japan, hepatocellular carcinoma is one of the most fatal malignant diseases.
According to the collected series by the Liver Cancer Study Group of Japan, about
80% of the patients had liver cirrhosis, especially post-hepatitis type, among 2300
cases of hepatocellular carcinoma diagnosed in Japan during 2 years from Jan. 1,
1984 to Dec. 31, 1985. Of the patients with liver cirrhosis, hepatitis B surface
antigen was positive in only 24.6%.
In the suburban hospital, Washington D.C., shown in this paper, only 30% of the
patients had liver cirrhosis. This figure is much smaller than in Japan. Because
hepatocellular carcinoma in this series were considered to be far advanced and
large in size, liver-spleen scan was very valuable for diagnosis. However, liver-
spleen scan is certainly not reliable for diagnosis of a minute hepatocellular
carcinoma in Japan. Ultrasonography, CT scan and Angiography are widely used,
showing over 90% reliability. In this series, AFP was positive in only 50% of
patients and recently in Japan it was positive (more thn 200ng/ml) in about 60% of
the patients, but sequential measurement of AFP is useful for diagnosis of
hepatocellular carcinoma in cirrhotic patients. I am surprised at the high incidence
of CEA-positivity in this series, because in only a few patients was CEA positive in
Japan. In this series, 48% of the patients had multicentric tumors, but many of
them may be multiple intrahepatic metastases because of the tendency of hepato-
cellular carcinoma to metastasize through portal vein.
The prognosis of hepatocellular carcinoma is poor in general. In the recently
collected series in Japan, however, the 5-year cumulative survival rate was about
30% in hepatectomy cases with resection rate of 60% or more and it was over 50%
in cases with curative resection.
I have much interest in the cohort analysis in this paper, showing apparent
increase of hepatocellular carcinoma in men born in 1911-1930, suggesting that the
development of hepatocellular carcinoma was closely related to World War II.PRIMARY HEPATOCELLULAR CARCINOMA 19
However, the evidence that the endemic environment during World War II may
induce hepatocellular carcinoma was not shown. Further analysis is required for co-
morbid diseases, such as a history of hepatitis, and blood transfusion, etc.
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